FDA establishment 3002663381, New York, New York, United States. Part of New York Blood Center's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations.
FY2018 to FY2027 to date; 0 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
Inspections citing each reference
| Ended | Product and area | Citations | Classification |
|---|---|---|---|
| Jul 17, 2026 | Biologics · Human Cellular, Tissue, and Gene TherapiesBiologics · Blood and Blood Products | 3 cited references
| No Action Indicated (NAI) |
| Sep 30, 2022 | Biologics · Blood and Blood ProductsBiologics · Vaccines and Allergenic Products | None posted | No Action Indicated (NAI) |
| Sep 19, 2018 | Biologics · Blood and Blood Products | None posted | No Action Indicated (NAI) |
| Feb 26, 2016 | Biologics · Blood and Blood Products | None posted | No Action Indicated (NAI) |
| Jun 24, 2014 | Biologics · Blood and Blood Products | None posted | No Action Indicated (NAI) |
| Oct 5, 2011 | Biologics · Blood and Blood Products | None posted | No Action Indicated (NAI) |
| Dec 14, 2009 | Biologics · Blood and Blood Products | None posted | No Action Indicated (NAI) |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard, warning letters and enforcement reports
New York, New York, United States. Part of